Evidence map›Paper›PMID 26002904›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2015

Living-Donor Kidney Transplantation: Reducing Financial Barriers to Live Kidney Donation--Recommendations from a Consensus Conference.

Lara Tushla, Dianne LaPointe Rudow, Jennifer Milton, James R Rodrigue, Jesse D Schold, Rebecca Hays, American Society of Transplantation

Registry-linked trialOpen access · bronzeAbstract readConsensus Statement
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03338140 (Assistant Lecturer of Urology in Assiut University), which is not on this map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03338140 unknown statusnot on this mapstarted 2017, after this paper: background citation

Assistant Lecturer of Urology in Assiut University

TypeobservationalSponsorAssiut UniversityRan2017 to 2019Enrolled50ConditionsRenal Transplantation
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 123 citations in OpenAlex.

  1. Non-medical barriers reported by nephrologists when providing renal replacement therapy or comprehensive conservative management to end-stage kidney disease patients: a systematic review.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Pooled it
  2. Guideline
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Financial toxicity in living donor liver transplantation: A call to action for financial neutrality.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Trends in kidney transplantation rate across Europe: study from the ERA Registry.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Lara TushlaUniversity Transplant Program, Rush University Medical Center, Chicago, Illinois; Lara_E_Tushla@rush.edu.
Dianne LaPointe RudowRecanati Miller Transplantation Institute, Mount Sinai Medical Center, New York, New York;
Jennifer MiltonUniversity of Texas Health Science Center of San Antonio, San Antonio, Texas;
James R RodrigueTransplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts;
Jesse D ScholdDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio; and.
Rebecca HaysTransplant Center, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
American Society of Transplantation
Beth Israel Deaconess Medical Center · USCleveland Clinic · USMount Sinai Medical Center · USThe University of Texas Health Science Center at San Antonio · USUW Health University Hospital · US

Funding

Kidney Donor Outcomes Cohort (KDOC) StudyR01DK085185 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANDELBROT, DIDIER A, RODRIGUE, JAMES R · 2011 to 2014
$2.8M
A Randomized Trial and Reduce to Disparity in Live Donor Kidney TransplantationR01DK079665 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI RODRIGUE, JAMES R · 2007 to 2011
$1.3M
NIDDK NIH HHS R01-DK079665NIDDK NIH HHS R01-DK085185
6 · The paper itself

Abstract

Live-donor kidney transplantation (LDKT) is the best treatment for eligible people with late-stage kidney disease. Despite this, living kidney donation rates have declined in the United States in recent years. A potential source of this decline is the financial impact on potential and actual living kidney donors (LKDs). Recent evidence indicates that the economic climate may be associated with the decline in LDKT and that there are nontrivial financial ramifications for some LKDs. In June 2014, the American Society of Transplantation's Live Donor Community of Practice convened a Consensus Conference on Best Practices in Live Kidney Donation. The conference included transplant professionals, patients, and other key stakeholders (with the financial support of 10 other organizations) and sought to identify best practices, knowledge gaps, and opportunities pertaining to living kidney donation. This workgroup was tasked with exploring systemic and financial barriers to living kidney donation. The workgroup reviewed literature that assessed the financial effect of living kidney donation, analyzed employment and insurance factors, discussed international models for addressing direct and indirect costs faced by LKDs, and summarized current available resources. The workgroup developed the following series of recommendations to reduce financial and systemic barriers and achieve financial neutrality for LKDs: (1) allocate resources for standardized reimbursement of LKDs' lost wages and incidental costs; (2) pass legislation to offer employment and insurability protections to LKDs; (3) create an LKD financial toolkit to provide standardized, vetted education to donors and providers about options to maximize donor coverage and minimize financial effect within the current climate; and (4) promote further research to identify systemic barriers to living donation and LDKT to ensure the creation of mitigation strategies.

Indexed as

Insurance CoverageInsurance, HealthLiving DonorsReimbursement MechanismsConsensusEmploymentHealth Services AccessibilityHousingHumansKidney TransplantationSalaries and Fringe BenefitsTransportationeconomic impactkidney donationkidney transplantationorgan transplant

Identifiers

PMID26002904
PMCPMC4559503
OpenAlexW2262731326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.